Boston Scientific reports quarterly loss

  • by: JAMES WALSH , Star Tribune
  • Updated: July 26, 2012 - 8:13 PM

Inplantable cardiac devices and heart stents drove a sales decline.

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT